AI-powered earnings analysis with management quotes, bull/bear cases, and financial breakdowns for 400+ public companies.
Grindr's earnings spark debate over price hikes versus user love.
With AI innovation fueling growth, OneStream’s earnings are a tidal wave for investors, despite looming federal uncertainties.
AMC's earnings reveal a tough ticket in uncertain times—will premium formats save the show?
Despite a 77.1% revenue surge, CWAN's stock takes a dive as growth debates swirl.
Ginkgo's ambitious RAC rollout faces tough growing pains amidst a sharp earnings drop and market skepticism.
Monster Beverage roars ahead, but will competition take the fizz out of future expansion?
Despite solid enterprise momentum, SMB struggles may dampen Sprout's sunny outlook.
Diamondback's stellar Q3 is overshadowed by macro headwinds and a stock slide, keeping investors on edge.
Despite 53% revenue growth, Hinge Health's stock dive raises questions on balancing AI gains with market challenges.
Norwegian's family focus waves goodbye to profits as stocks splash down 15.3%.
Despite competitive bumps, Progressive navigates to strong revenue growth and keeps its margins safely in the fast lane.
Confluent's cloud might be stabilizing, but their real-time revenue is thriving amidst the optimization chatter.
Despite solid revenue growth, Schwab feels the pressure as market waves rock its stock.
A mixed bag for Zegna as stock rises despite revenue dip; can it stitch together long-term growth?
With flat stocks and ITC worries, Pineapple Energy faces a tough time navigating its financial future.
Universal Music's earnings hit a high note, yet concerns over streaming shake investor confidence.
Hologic's growth wobbles as tariff tensions and market maturity loom over its Breast Health bounce-back.
Despite strong gains, EA faces tough competition as it bets big on Battlefield 6 and sports franchises.
Despite impressive growth, Rubrik's stock struggles as identity resilience faces growing pains.
Despite 26.6% revenue growth, market jitters knock ServiceTitan down 9%—is expansion worth the risk?
Core Scientific's revenue plunge raises eyebrows, yet the stock rebound hints at a strategic pivot in the AI game.
Walgreens delivers a double shot of growth, but is the pharmacy's future on the line amidst contract negotiations?
Smartsheet's Q2 bounce raises hopes, but new pricing could stir doubts among users and investors.
Berkshire's cash hoarding raises eyebrows as it trims Apple; is caution the new king of the investment castle?